HomeCompareCYSNF vs MRK

CYSNF vs MRK: Dividend Comparison 2026

CYSNF yields 1.30% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.9K in total portfolio value
10 years
CYSNF
CYSNF
● Live price
1.30%
Share price
$0.69
Annual div
$0.01
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.9K
Annual income
$0.13
Full CYSNF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CYSNF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCYSNFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CYSNF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CYSNF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYSNF
Annual income on $10K today (after 15% tax)
$110.62/yr
After 10yr DRIP, annual income (after tax)
$0.11/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,328.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYSNF + MRK for your $10,000?

CYSNF: 50%MRK: 50%
100% MRK50/50100% CYSNF
Portfolio after 10yr
$38.3K
Annual income
$4,899.13/yr
Blended yield
12.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CYSNF
No analyst data
Altman Z
11.3
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYSNF buys
0
MRK buys
0
No recent congressional trades found for CYSNF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCYSNFMRK
Forward yield1.30%2.76%
Annual dividend / share$0.01$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$19.9K$56.8K
Annual income after 10y$0.13$9,798.13
Total dividends collected$131.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CYSNF vs MRK ($10,000, DRIP)

YearCYSNF PortfolioCYSNF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,765$65.07$11,206$366.19$441.00MRK
2$11,551$32.73$12,650$502.35$1.1KMRK
3$12,376$16.41$14,407$694.19$2.0KMRK
4$13,251$8.22$16,585$967.82$3.3KMRK
5$14,183$4.11$19,342$1,363.89$5.2KMRK
6$15,177$2.06$22,913$1,947.19$7.7KMRK
7$16,241$1.03$27,662$2,823.89$11.4KMRK
8$17,378$0.51$34,159$4,173.35$16.8KMRK
9$18,595$0.26$43,337$6,308.80$24.7KMRK
10$19,897$0.13$56,776$9,798.13$36.9KMRK

CYSNF vs MRK: Complete Analysis 2026

CYSNFStock

C-Com Satellite Systems Inc. develops and deploys commercial grade mobile auto-deploying satellite-based technology for the delivery of two-way high-speed Internet, VoIP, and video services into vehicles. The company offers iNetVu, a proprietary mobile auto-deploying antenna for the delivery of satellite-based Internet services into vehicles while stationary virtually anywhere one can drive. It also provides driveaway, flyaway, manpack, and fixed motorized antennas. In addition, the company offers accessories, such as powersmart products, beacon receivers, transportable cases, transportable enclosed skids, custom integrations, and satellite system cables as well as controllers. Its products and services deliver solutions for fixed and mobile applications. The company serves governments, militaries, oil and gas companies, broadcasters, emergency responders, hospitals, banks, schools, race teams, mining companies, and other sectors. It operates in Canada, Japan, Europe, the United States, Asia, and internationally. C-Com Satellite Systems Inc. was incorporated in 1997 and is headquartered in Ottawa, Canada.

Full CYSNF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CYSNF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYSNF vs SCHDCYSNF vs JEPICYSNF vs OCYSNF vs KOCYSNF vs MAINCYSNF vs JNJCYSNF vs ABBVCYSNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.